Amesite Inc. stocks have been trading up by 172.23 percent amid heightened optimism over its latest AI education platform developments.
Click Here for a Millionaire's POV on Trading AMST
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Amesite announced its largest NurseMagic deployment to date with a new enterprise home-care customer covering roughly 2,700 patients.
- The NurseMagic implementation integrates EMR and electronic visit verification workflows and is positioned to materially cut caregiver documentation time.
- Management points to the new deployment as validation of NurseMagic’s scalability and Amesite’s enterprise-focused strategy.
- Amesite announced an insider-led private placement at a premium to market, alongside a concurrent registered direct offering and private placement expected to raise about $2.6M in gross proceeds.
- The capital raise is intended to restore Nasdaq stockholders’ equity compliance above the $2.5M threshold.
Live Update At 10:04:01 EDT: On Tuesday, May 19, 2026 Amesite Inc. stock [NASDAQ: AMST] is trending up by 172.23%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
AMST has been trading like a classic low-float runner. Over the past few weeks, Amesite Inc. slid from the $1.50s–$1.60s range on 2026/04/24 down under $1, then suddenly exploded to an intraday high near $3.40 on 2026/05/19 before closing around $2.14. That kind of volatility is exactly what short-term traders hunt.
Zooming in, the intraday 5‑minute chart shows AMST ripping from the $1.40s at 04:00 up through the $2.50s and even tapping above $3.00 before pulling back and churning between $2.10 and $2.70. This is a textbook momentum surge followed by profit-taking and consolidation.
More Breaking News
- Wingstop Stock Dips As Price Targets Cut Despite Earnings Beat
- MTVA Stock Sees Volatile Spike As Traders Eye Cash-Heavy Balance Sheet
- RXT Stock Rockets On Massive Volume As Traders Pile In
- AGYS Stock Jumps As Record Earnings Meet AI Momentum
Fundamentally, Amesite Inc. is still tiny, booking just about $110,000 in quarterly revenue and running heavy losses, with EBITDA around -$665,000 and net income near -$733,000. Margins are deeply negative and the company burns cash, with free cash flow at roughly -$665,000 for the reported quarter. On the plus side, AMST holds about $1.17M in cash, has no long‑term debt, and a current ratio of 2.7, giving it some breathing room. For traders, AMST is a story and momentum stock, not a value play.
Why Traders Are Watching AMST After NurseMagic News
Traders are crowding into AMST because the story finally has a clear catalyst. Amesite Inc. just landed its largest NurseMagic deployment to date, signing an enterprise home‑care customer that serves roughly 2,700 patients. In the micro‑cap world, that kind of contract looks big relative to the company’s current scale, and the tape is reacting.
The key detail is not just the size. The new NurseMagic rollout plugs directly into the customer’s electronic medical record (EMR) system and electronic visit verification workflows. That tells traders two things. First, NurseMagic is advanced enough to live inside real clinical operations, not just pilot projects. Second, once AMST gets embedded in those EMR and verification processes, ripping it out later becomes painful. That “stickiness” is what momentum traders like to see in an early‑stage tech name.
Management is framing this win as proof that NurseMagic can scale across large, complex enterprise customers. For Amesite Inc., which reported only about $108,000 in quarterly revenue, even a single solid enterprise contract can change the revenue trajectory and improve visibility. The market is trading that possibility aggressively.
Layer on top the earlier insider-led private placement at a premium to market, plus the concurrent registered direct and private deals expected to raise about $2.6M in gross proceeds. AMST used that move to restore Nasdaq stockholders’ equity compliance above $2.5M. For traders, this helps remove the delisting overhang and signals that insiders were willing to support Amesite Inc. at stronger prices. Combine fresh capital with a real product deployment, and you get the surge we’re seeing on the AMST chart.
Conclusion
AMST is still a high-risk, high‑volatility micro‑cap, but the narrative has shifted. Amesite Inc. is no longer trading purely on hope; it now has its largest NurseMagic enterprise deployment live, tied to 2,700 home‑care patients and dug into EMR and verification systems. That gives traders a concrete operational milestone to track instead of just a slide deck.
At the same time, the insider-led capital raise at a premium and the roughly $2.6M expected in gross proceeds helped restore Nasdaq equity compliance above $2.5M. That does mean dilution, but for many active traders, removing the delisting threat and extending runway for Amesite Inc. to scale NurseMagic is a fair trade-off.
The chart shows exactly how the market reacts when a beaten-down name like AMST finally lines up catalysts: a vertical move, wide ranges, and sharp pullbacks. This is where trade planning matters. As Tim Sykes loves to say, “The market rewards preparation, not prediction.” And as Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” For Amesite Inc. and AMST, the preparation means studying this price action, understanding the NurseMagic story, and knowing your risk levels before you ever hit the buy button. This article is for educational and research purposes only and is not investment advice.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.